CZIRR JAMES C

Average Profitability
<0.0001%
Insider Buys Quantity
3
Insider Buys Sum
$858,794.00
Insider Sells Quantity
30
Insider Sells Sum
$11.77M

Insider Activity of CZIRR JAMES C

According to the SEC Form 4 filings, CZIRR JAMES C, being in a position of

  1. 10 percent owner at Galectin Therapeutics Inc.,
    оver the last 12 months, has bought 0 shares, and sold 25000 shares for $76,500,
    over all time since 2003-10-06, has bought 422000 shares for $858,794, and sold 2039468 shares for $11.77M.

The largest purchase of all time was on 2007-11-09 and amounted to 400000 shares of Galectin Therapeutics Inc. for $800,000.

The largest sale of all time was on 2013-10-07 and amounted to 200000 shares of Galectin Therapeutics Inc. for $2.36M.

Biography of CZIRR JAMES C

No biography is available at this moment.

2024-04-23SaleGalectin Therapeutics Inc.
GALT
10 percent owner
3,677
0.0054%
$3.06$11,252-21.3%
2024-04-22SaleGalectin Therapeutics Inc.
GALT
10 percent owner
21,323
0.0344%
$3.06$65,248-12.79%
2022-07-22SaleGalectin Therapeutics Inc.
GALT
10,000
0.019%
$2.09$20,870-11.89%
2018-06-18SaleGalectin Therapeutics Inc.
GALT
director
60,000
0.1552%
$9.06$543,600-47.27%
2018-06-15SaleGalectin Therapeutics Inc.
GALT
director
15,475
0.0392%
$8.47$131,073-44.69%
2018-06-14SaleGalectin Therapeutics Inc.
GALT
director
76,385
0.2027%
$8.28$632,133-40.69%
2018-06-13SaleGalectin Therapeutics Inc.
GALT
director
208,140
0.4995%
$7.17$1.49M-38.11%
2018-06-08SaleGalectin Therapeutics Inc.
GALT
director
110,000
0.2742%
$5.88$646,800-20.99%
2018-06-04SaleGalectin Therapeutics Inc.
GALT
director
8,093
0.0214%
$5.13$41,517-3.94%
2018-06-01SaleGalectin Therapeutics Inc.
GALT
director
41,907
0.1148%
$5.12$214,564+0.31%
2018-01-26SaleGalectin Therapeutics Inc.
GALT
director
39,300
0.1044%
$5.35$210,255-12.22%
2018-01-25SaleGalectin Therapeutics Inc.
GALT
director
205,144
0.5701%
$5.45$1.12M-9.89%
2016-04-20SaleGalectin Therapeutics Inc.
GALT
director
22,424
0.0821%
$1.57$35,273-0.68%
2016-04-19SaleGalectin Therapeutics Inc.
GALT
director
66,200
0.2323%
$1.68$111,229-10.91%
2014-01-13SaleGalectin Therapeutics Inc.
GALT
Executive Chairman
116,000
0.5954%
$14.00$1.62M-18.24%
2014-01-10SaleGalectin Therapeutics Inc.
GALT
Executive Chairman
84,000
0.4392%
$16.00$1.34M-26.16%
2013-11-15PurchaseGalectin Therapeutics Inc.
GALT
Executive Chairman
2,000
0.0117%
$6.90$13,794+61.42%
2013-10-08SaleGalectin Therapeutics Inc.
GALT
Executive Chairman
24,000
0.1571%
$12.36$296,539+1.22%
2013-10-07SaleGalectin Therapeutics Inc.
GALT
Executive Chairman
200,000
1.1511%
$11.79$2.36M-6.76%
2012-05-17PurchaseGalectin Therapeutics Inc.
GALT
Executive Chairman
20,000
0.1418%
$2.25$45,000+9.16%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.